The average Valeant Pharmaceuticals International Sr Financial Analyst earns an estimated $89,326 annually, which includes an estimated base salary of $76,925 with a $12,401 bonus. Valeant Pharmaceuticals International's Sr Financial Analyst compensation is $1,927 more than the US average for a Sr Financial Analyst. Sr Financial Analyst salaries at Valeant Pharmaceuticals International can range from $52,000 - $185,000.
The Finance Department at Valeant Pharmaceuticals International earns $2,225 more on average than the Marketing Department.
Last updated 2 years ago.
Sr Financial Analysts earn $5,009 more than Financial Analysts, and $1,830 less than Business Analysts.
The Finance Department averages $2,225 more than the Marketing Department, and $1,289 less than the Sales Department
The average female Sr Financial Analyst at companies similar size to Valeant Pharmaceuticals International reported making $93,556, while the average male Sr Financial Analyst at similar sized companies reported making $91,853.
The average Asian or Pacific Islander Sr Financial Analyst at companies similar size to Valeant Pharmaceuticals International reported making $98,729, while the average Native American Sr Financial Analyst at similar sized companies reported making $60,000.
The majority of Sr Financial Analysts at Valeant Pharmaceuticals International believe they're compensated fairly. The vast majority (80%) of Sr Financial Analysts at Valeant Pharmaceuticals International are satisfied with their benefits. See more compensation ratings at Valeant Pharmaceuticals International